MedTrace Logo

Behavioral Science and Hepatitis C Screening Outreach

NCT03712553 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21493

Last updated 2020-12-01

No results posted yet for this study

Summary

This project aims to evaluate different approaches to increase Hepatitis C screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, we will evaluate different approaches to increase completion of screening among eligible patients, including changing the default from opt-in to opt-out and incorporating behavioral science principles into the outreach communication.

Conditions

  • Hepatitis C

Interventions

BEHAVIORAL

Opt-Out

Opt-In messaging prompts participants to contact their primary care provider to receive Hepatitis C screening whereas Opt-Out messaging includes a signed laboratory order for Hepatitis C screening.

BEHAVIORAL

Letter

Participants receive messaging prompting them to contact their primary care provider to receive Hepatitis C screening, either as a letter or an electronic message on the MyPennMedicine patient portal.

BEHAVIORAL

Behavioral Economic Messaging

Participants receive standard messaging about HCV and ways to get screened and messaging that incorporates behavioral economic principles such as norms, reciprocity, anticipated regret, and pre-commitment to get screening.

BEHAVIORAL

Usual Care Messaging

Participants receive standard messaging about HCV and ways to get screening.

Sponsors & Collaborators

Principal Investigators

  • Shivan Mehta, MD, MBA · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
53 Years
Max Age
73 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-15
Primary Completion
2020-10-15
Completion
2020-10-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03712553 on ClinicalTrials.gov